NB-005 (Suzhou Luosheng Bio-Pharmaceutical)

N/A

Report date: 2024/07/03 10:53:10

Base Information

Drug NameNB-005 (Suzhou Luosheng Bio-Pharmaceutical)

Drug Alias NameNB-005NB-005 (Suzhou Luosheng Bio-Pharmaceutical)NB-005 (逻晟生物)NB-005.1

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human

Mechanisms of ActionKiller cell lectin-like receptor subfamily G member 1 antagonists

TargetsKiller cell lectin-like receptor subfamily G member 1

Therapy Area/IndicationsAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNeoLogics Bioscience Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesNeoLogics Bioscience Co Ltd

Inactive CompaniesN/A

Active IndicationsAutoimmune Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A